HF

SURG

Workshop

TRANSCATHETER MITRAL AND TRICUSPID INTERVENTIONS: READY FOR PRIME TIME?

Co-Chair(s)

• 

  Anique Ducharme, MD FRCPC

  Professor of Medicine, Heart Failure/Transplant Cardiologist
  Montreal Heart Institute
  University of Montreal
• Denis B.

  Denis Bouchard, MD, PhD

  Cardiac Surgeon
  Montreal Heart Institute
  Université de Montréal

Presenter(s)

• 

  Anita Asgar, MD, MSc

  Director, Transcatheter Valve Therapy Research
  Montreal Heart Institute
  Université de Montréal
• Neil F.

  Neil Fam, MD, PhD

  Interventional Cardiologist
  University of Toronto
• Rob B.

  Rob Boone, MD, PhD

  Interventional Cardiologist
  University of BC
• Luc P.

  Luc Pham

  Cardiologist
• Sandra L.

  Sandra Lauck, PhD

  Nursing
  UBC
  University of British Columbia

Percutaneous valvular interventions for mitral and tricuspid regurgitation is a rapidly growing field aimed at improving symptoms, minimizing cardiovascular morbidity and possibly increase longevity. Cardiac imaging plays an essential role in the baseline assessment and serial follow-up of valvular heart disease as well as the decision making for intervention. Decision to intervene or not is individualized based on a heart team discussion. This workshop calls upon the expertise of individuals with various and complementary expertise and audience interaction to highlight the decision making process and provide understanding into the mechanisms of valvular incompetency in the context of heart failure.

 

Learning Objectives

At the conclusion of this session, participants will be able to:

• understand the clinical challenges of mitral and tricuspid regurgitation and treatment options;
• understand the data supporting treatment of Functional mitral regurgitation; and
• understand clinical indications for transcatheter treatment of mitral and tricuspid regurgitation.